Sofosbuvir and Velpatasvir 400 mg/1
Velpatasvir and Sofosbuvir · TABLET, FILM COATED · Asegua Therapeutics LLC
No Recall History
Plain English
Sofosbuvir and Velpatasvir is a tablet, film coated containing velpatasvir and sofosbuvir at 400 mg/1, taken oral. Manufactured by Asegua Therapeutics LLC.
Key Facts
- Brand Name
- Sofosbuvir and Velpatasvir
- Generic Name
- Velpatasvir and Sofosbuvir
- NDC Code (Product)
72626-2701- Manufacturer
- Asegua Therapeutics LLC
- Strength
- 400 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA208341
- Drug Class
- Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]; Hepatitis C Virus NS5A Inhibitor [EPC]
- Marketing Start
- 11/14/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Sofosbuvir and Velpatasvir used for?
Sofosbuvir and Velpatasvir contains Velpatasvir and Sofosbuvir. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Sofosbuvir and Velpatasvir a controlled substance?
Sofosbuvir and Velpatasvir is not classified as a controlled substance by the DEA.
What is the generic name for Sofosbuvir and Velpatasvir?
The generic name for Sofosbuvir and Velpatasvir is Velpatasvir and Sofosbuvir. There are 4 other brand versions of Velpatasvir and Sofosbuvir.
What is the NDC code for Sofosbuvir and Velpatasvir 400 mg/1?
The NDC (National Drug Code) for Sofosbuvir and Velpatasvir 400 mg/1 is 72626-2701, listed by Asegua Therapeutics LLC.